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Abstract
Introduction: Anaesthesia procedures for surgical interventions in patients with amyotrophic
lateral sclerosis (ALS) are not commonly found in clinical practice, and often have special
considerations that must be taken into account in treatment planning. As a result, these procedures
are rarely subject to publication, rendering it difficult for the anaesthesiologists to find useful and
reliable information on this topic. ALS also presents a contraindication to the use of
nondepolarising neuromuscular blocking drugs during general anaesthesia.
Case presentation: In the case presented here, a 52-year old, White man, the progression of the
disease to tetraparesis and respiratory failure, in addition to having the patient on chronic
mechanical ventilation support, provided additional challenges to the handling team. The
maturation of cataracts severely impaired communication with the patient, and surgical treatment
of the cataract presented the only means to save communication. Such interventions are generally
performed under local anaesthesia with the advice of the attending anaesthesiologist. However, in
this case the patients' announcements during the operation would be unreadable to the advising
anaesthesiologist. Here, the authors share experiences from a successfully applied combination of
topical and general anaesthesia for two cataract operations and a vitrectomy. This was tolerated
well by the patient, and without any side-effects.
Conclusion: The applied treatment resulted in a substantial improvement of the vision and
allowed communication to be maintained with the patient.
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Introduction
Anaesthesia procedures in patients with amyotrophic lat-
eral sclerosis (ALS, Lou Gehrig's disease) often require cer-
tain special considerations [1]. However, surgical
interventions in patients with advanced ALS are uncom-
mon and, consequently, are rarely subject to publication,
resulting in a lack of literature on this topic. To our knowl-
edge there have been no reports published on anaesthesia
procedures in ophthalmologic operations in patients with
ALS. Thus, this work presents an example of successful
anaesthesia procedures provided for two cataract opera-
tions in a man with advanced ALS on mechanical ventila-
tion.
Case presentation
A 52-year old, White man (height of 1.72 m, bodyweight
of 78 kg) showed signs of limping in the right leg begin-
ning in January 1998. No neurologic disorders had been
previously diagnosed in the family. The patient had expe-
rienced a neck and occiput injury (struck with a stone)
about 20 years earlier, but this was resolved without com-
plications. Information on smoking was unavailable, and
the patient occasionally consumed small amounts of alco-
hol.
Initially, the Neurology Department suspected a motor
neuron disease and, due to initial uncertainties with the
diagnosis, the patient was consulted at a national refer-
ence centre for motor neuron disease, where the diagnosis
of ALS was ultimately confirmed 15 months after disease
onset. Riluzole (Rilutek, Aventis Pharma, France) was
introduced as the sole medication.
Twelve months after the disease onset the patient was
forced to begin using a wheel chair, and, after another
eight months, hypoventilation developed. The patient
became dyspneic and was directed to the Infectious Dis-
eases Department Intensive Care Unit to consider the
option of chronic mechanical ventilation support. Fol-
lowing admission to the hospital, the patient was exten-
sively informed about the benefits and disadvantages of
chronic mechanical ventilation support, and a written
consent was obtained. Tracheal intubation was per-
formed, followed by a tracheostomy and introduction of
chronic mechanical ventilation support with a Nellcor
Puritan-Bennet 740 ventilator. The progression of the dis-
ease could be clearly observed over the course of the next
six years. The upper and lower extremities became totally
paralyzed, and the bulbar nerves became afflicted – the
patient lost the ability to move, swallow, and whisper.
With time, communication with the patient became pos-
sible only with the use of an alphabet table or a text editor
supported by a photomechanically controlled keyboard
linked to a computer. The first signs of cataracts appeared
in the summer of 2005. Deterioration of eyelid winking
occurred simultaneously. The rapid maturation of the cat-
aract resulted in a nearly complete loss of communication
with the patient – he was unable to use either the elec-
tronic writing device or the alphabet table. A decision
regarding surgical treatment of the cataract was made by a
council consisting of the engaged physicians and the con-
sulting ophthalmologists.
The first phacoemulsification of the right eye took place
on November 17, 2005. Preparation for this operation
included the insertion of a central venous catheter via the
left subclavian vein, and insertion of a urinary catheter.
Before entering the operation room (OR), the patient
received premedication consisting of pethidine (1 mg·kg-
1) and midazolam (0.1 mg·kg-1) applied intramuscularly.
ECG monitoring, non-invasive arterial blood pressure,
pulsoximetry, and capnometry were carried out in the OR.
General anaesthesia was introduced by a bolus injection
of propofol (1 mg·kg-1), and was supported by volatile
anaesthesia consisting of 65 vol% N2O, 0.7 vol% sevoflu-
rane, and oxygen administered by a volume controlled
anaesthesia ventilator through the tracheostomy tube,
using a circle circuit with a CO2 absorber. Furthermore,
the operating surgeon anaesthetized the eye by topical
administration of proxymetacaine 0.5% eye drops. The
ophthalmologic procedure lasted 25 minutes, without
any complications. Following the operation, delivery of
the volatile anaesthetics was ceased and the patient was
transported back to the recovery room. He became
responsive to alerts 20 minutes after discontinuation of
the volatile anaesthetics. The total anaesthesia handling in
the OR lasted 40 min, and the stay in the recovery room
lasted 3 hours.
The outcome from the first operation was complicated by
development of an endophthalmitis with choroids
inflammation, due to a methicillin-resistant Staphylococcus
epidermidis strain. Although the infection was successfully
treated with topical and systemic antibiotics, corticoster-
oids, and non-steroid anti-inflammatory drugs, residual
postinflammatory membranes impaired the vision and
necessitated further surgical treatment. The second opera-
tion, consisting of the phacoemulsification of the left eye
and a vitrectomy due to the endophthalmitis of the right
eye, took place on December 20, 2005. The preparation
for the operation was similar to the first one. Again, gen-
eral anaesthesia was introduced by an intravenous bolus
of propofol and sustained by volatile anaesthesia. For the
most painful stages of the operation (vitrectomy), an
additional bolus of propofol and fentanyl was adminis-
tered. The ophthalmologic procedures lasted 100 min.,
the anaesthesiologic – 130 min. The patient stayed again
for two hours in the recovery room before he was trans-
ported back to his room.Cases Journal 2008, 1:338 http://www.casesjournal.com/content/1/1/338
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The treatment and rehabilitation after the second opera-
tion took about three months, but resulted in substantial
improvement in vision and the maintenance of satisfac-
tory communication with the patient. Two years after the
ophthalmologic interventions the patient remained in a
relatively stable condition, with communication still
intact.
Discussion
The progressive stage of the ALS and no publications
describing the anaesthesiological procedures for ophthal-
mologic surgery in patients with this disease provided a
serious challenge to the handling team.
Amyotrophic lateral sclerosis is a progressive, usually
lethal, neurodegenerative disease that occurs mainly after
the age of 50. It is the most common and most severe of
the motor neuron diseases [2-4]. The annual incidence
rate is roughly 1–2.5 per 100,000 [5-7]. Although heredi-
tary cases and the familial coincidence of ALS with
dementia and parkinsonism have been described, in the
majority of patients the disease onset is sporadic [3,4].
The precise pathological mechanism leading to the death
of motor neurons is complex and not well understood.
The known molecular pathways that may be involved are
more clearly identified in familial ALS [3,4]. Pathological
insights are primarily derived from animal studies and
include, among others, defects of superoxide dismutase –
1, disorganization of the intermediate filament, abnormal
intracellular free calcium levels, and glutamate excitotox-
icity which are considered to be responsible for mitochon-
drial abnormalities and energetic distress leading to cell
injury and motor neuron death [3,4,8]. In addition,
recently published genomic studies identified a few other
genetic loci significantly associated with ALS [9].
ALS presents with muscle fasciculation, palsy, and spastic-
ity, and usually results in death from respiratory failure
due to hypoventilation within one to three years [4]. In
some cases the onset is marked by bulbar nerve involve-
ment, and then the disease presents with dysarthria, dys-
phagia, and dyspnea. Mechanical ventilation support can
prolong the survival. Non-invasive methods of ventilation
support are preferred before tracheostomy, but in 1999
non-invasive ventilation was not available to the handling
team [10]. Therefore, invasive mechanical ventilation
could only be offered to the patient as an alternative to
palliative care.
At our Ophthalmology Department the phacoemulsifica-
tion of a cataract is routinely done under topical anaesthe-
sia with proxymetacaine 0.5% eye drops and/or
peribulbar anaesthesia with lidocaine 2%, which is
administered by the surgeon [11,12]. An anaesthesiolo-
gist usually assists the procedure with a monitored advice.
The sedated, but not anaesthetized patient remains
responsive to the surgeon and anaesthesiologist, allowing
for the administering of additional topical or intravenous
analgetics on request when regional anaesthesia causes
anxiety or provides insufficient pain relief.
In the presented case the patient's alerts would be uniden-
tifiable by the supervising anaesthesiologist due to the
advanced motor paralysis and tracheostomy. Therefore,
the method of choice, considered by the authors to guar-
antee the most comfortable state through the operation,
was a combination of topical anaesthesia with slight gen-
eral volatile anaesthesia. An intravenous bolus of propo-
fol was used for a swifter induction of anaesthesia.
A special consideration must be taken into account for
patients with ALS that require a neuromuscular blockade.
Nondepolarising neuromuscular blocking drugs are rou-
tinely used during general anaesthesia to achieve suffi-
cient muscle relaxation, providing good conditions for
performing surgical procedures. However, an increased
susceptibility to nondepolarising neuromuscular block-
ing drugs is present in patients with motor neuron disease.
These drugs should either be entirely avoided in those
patients or only used with caution following a regional
curare test, under the control of a peripheral nerve stimu-
lation monitor [12-15]. Depolarizing neuromuscular
blocking drugs may also elicit myotonic reactions and
massive hyperkalaemia in these patients [1,16-19]. In the
presented case the authors avoided neuromuscular block-
ing drugs and, furthermore, there was no need for them
due to the disease progression.
The arterial blood pressure and heart rate remained stable
throughout both operations. In addition, no other signs
of pain perception, such as sweating or rush, were noted.
A follow-up on the day after the operation confirmed the
patients' full satisfaction from the applied method in both
operations.
Conclusion
In preparing the algorithm for the anaesthesiological pro-
cedures used in the presented case, the authors compiled
clinical experience and scarce information from literature.
The applied combination of topical and volatile anaesthe-
sia with intravenous induction was well tolerated, and
provided no side-effects in a patient with advanced amyo-
trophic lateral sclerosis, who sustained two operations for
a cataract and a vitrectomy. The applied treatment
resulted in substantial vision improvement and allowed
continued communication with the patient.
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